Self-monitoring and Reminder Texts to Increase Physical Activity After Cancer II
- Conditions
- Colorectal CancerColon CancerRectal Cancer
- Interventions
- Behavioral: Fitbit and Text Messages
- Registration Number
- NCT03524716
- Lead Sponsor
- University of California, San Francisco
- Brief Summary
There is a critical need for physical activity interventions in colorectal cancer (CRC). The investigators have developed a digital health physical activity intervention, Smart Pace, which includes a wearable tracker (Fitbit) and text messaging and aims to have patients build up to 150 min/wk of moderate activity. In this study, the investigators propose to expand and improve Smart Pace, including: 1) enrolling patients during chemotherapy; 2) tailoring text messages to individual preferences and treatment timing; and 3) adding resources to support home-based exercise. The study is a 12-week pilot randomized controlled trial (RCT) to evaluate the feasibility of this novel digital health physical activity intervention among 48 CRC patients on chemotherapy. The specific aims are to: 1) Determine the feasibility of the intervention via adherence and attrition, and determine the acceptability of the intervention via questionnaires and semi-structured interviews . 2) Estimate the effect of the intervention vs. usual care on physical activity, QOL, and symptoms at 12-weeks . And 3) Explore the impact of the intervention vs. usual care on fitness, weight, waist circumference, and blood pressure at 12-weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44
- Diagnosed with colon or rectal adenocarcinoma
- Expected to receive at least 12 weeks of chemotherapy
- Able to speak and read English
- Access to a mobile phone with Internet and text messaging capabilities
- ≥4 weeks since last major surgery and fully recovered
- ≥18 years old
- Physician consent to participate in unsupervised moderate intensity physical activity
- Eastern Cooperative Oncology Group (ECOG) performance status 0-1
- Engaging in 150 minutes/week or more of moderate physical activity, 75 minutes/week or more of vigorous physical activity, or an equivalent combination
- Hypertension that is not well-controlled (≥160/90) on anti-hypertensive therapy
- Any contraindications to exercise, including, but not limited to: brain metastases; current congestive heart failure (New York Heart Association Class II, III or IV); serious or nonhealing wound, ulcer, or bone fracture; spinal cord compromise or instrumentation due to metastatic disease; peripheral neuropathy ≥grade 3; advanced Chronic Obstructive Pulmonary Disease (COPD) on oxygen
- Serious cardiovascular event within 6 months including, but not limited to, transient ischemic attack (TIA), cerebrovascular accident (CVA), or myocardial infarction (MI)
- Has been told by a doctor that he/she has a heart condition and recommended to only engage in medically supervised activity
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Fitbit and Text Messages Fitbit and Text Messages Participants randomized to this arm receive print materials and a Fitbit Flex 2 at baseline and daily text messages for 12 weeks.
- Primary Outcome Measures
Name Time Method Fitbit wear time up to 12 weeks from study start Number of study days Fitbit is worn
Acceptability of the intervention At 12 weeks from study start Acceptability will be assessed with an investigator created questionnaire among participants in the intervention arm.
Text message response rate up to 12 weeks from study start
- Secondary Outcome Measures
Name Time Method Objective physical activity At 0 weeks and 12 weeks from study start Minutes of moderate-to-vigorous physical activity per week measured by accelerometer
Fatigue At 0 and 12 weeks from study start Lee Fatigue Scale
Cardiorespiratory fitness At 0 and 12 weeks from study start 6 minute walk test
Anthropometrics, Waist circumference At 0 and 12 weeks from study start Anthropometrics, Body weight At 0 and 12 weeks from study start Sleep quality At 0 and 12 weeks from study start Will be assessed by the Pittsburgh Sleep Quality Index, providing a score ranging from 0 to 21, where lower scores denote a healthier sleep quality.
Health-related quality of life in cancer patients At 0 and 12 weeks from study start Will be assessed via the European Organization for Research and Treatment (EORTC) of Cancer Quality of Life Questionnaire-Core 30
Health-related quality of life in colorectal cancer patients At 0 and 12 weeks from study start Will be assessed via the European Organization for Research and Treatment (EORTC) of Cancer Quality of Life Questionnaire-Core 29
Neuropathy At 0 and 12 weeks from study start Will be assessed by the Chemotherapy-Induced Peripheral Neuropathy 20 (CIPN20) questionnaire, a 20-item quality of life questionnaire.
Anxiety At 0 and 12 weeks from study start Will be assessed by the Spielberger State-Trait Anxiety Inventories (STAI), consisting of 40 questions on a self-report basis. Scores range from 20 to 80, with higher scores correlating with greater anxiety.
Depression At 0 and 12 weeks from study start Will be assessed by the Center for Epidemiological Studies-Depression Scale (CES-D), a brief self-report questionnaire which consists of 20 questions. Scores on the CES-D range from 0 to 60, in which higher scores suggest a greater presence of depressive symptoms.
Leisure-time physical activity At 0 and 12 weeks from study start Will be assessed via the Harvard Health Professionals Follow-up Study (HPFS) physical activity questionnaire.
Perceived barriers to physical activity At 0 and 12 weeks from study start Modified from the Project Graduate Ready for Activity Daily(GRAD) survey - 24 items plus a write-in option.
Exercise Confidence At 0 and 12 weeks from study start Modified from the Project GRAD (Graduate Ready for Activity Daily) survey - 11 items.
Social support At 0 and 12 weeks from study start Modified from the Project GRAD (Graduate Ready for Activity Daily) survey - 13 items asked about social support.
Trial Locations
- Locations (1)
University of California, San Francisco
🇺🇸San Francisco, California, United States